Literature DB >> 1521532

Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core.

C Battaglia1, U Mayer, M Aumailley, R Timpl.   

Abstract

A large, low-density form of heparan sulfate proteoglycan was isolated from the Engelbreth-Holm-Swarm (EHS) tumor and demonstrated to bind in immobilized-ligand assays to laminin fragment E3, collagen type IV, fibronectin and nidogen. The first three ligands mainly recognize the heparan sulfate chains, as shown by inhibition with heparin and heparan sulfate and by the failure to bind to the proteoglycan protein core. Nidogen, obtained from the EHS tumor or in recombinant form, binds exclusively to the protein core in a heparin-insensitive manner. Studies with other laminin fragments indicate that the fragment E3 possesses a unique binding site of laminin for the proteoglycan. A major binding site of nidogen was localized to its central globular domain G2 by using overlapping fragments. This allows for the formation of ternary complexes between laminin, nidogen and proteoglycan, suggesting a key role for nidogen in basement-membrane assembly. Evidence is provided for a second proteoglycan-binding site in the C-terminal globule G3 of nidogen, but this interaction prevents the formation of such ternary complexes. Therefore, the G3-mediated nidogen binding to laminin and proteoglycan are mutually exclusive.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521532     DOI: 10.1111/j.1432-1033.1992.tb17195.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  37 in total

1.  Differential regulation of the human nidogen gene promoter region by a novel cell-type-specific silencer element.

Authors:  M Zedlacher; M Schmoll; K Zimmermann; O Horstkorte; R Nischt
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

2.  Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin alpha3B and alpha5 chains.

Authors:  Jörg H O Garbe; Walter Göhring; Karlheinz Mann; Rupert Timpl; Takako Sasaki
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

3.  The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens.

Authors:  Daniel Timo Behrens; Daniela Villone; Manuel Koch; Georg Brunner; Lydia Sorokin; Horst Robenek; Leena Bruckner-Tuderman; Peter Bruckner; Uwe Hansen
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

Review 4.  Basement membranes in skin: unique matrix structures with diverse functions?

Authors:  Dirk Breitkreutz; Nicolae Mirancea; Roswitha Nischt
Journal:  Histochem Cell Biol       Date:  2009-03-31       Impact factor: 4.304

Review 5.  The role of laminins in basement membrane function.

Authors:  M Aumailley; N Smyth
Journal:  J Anat       Date:  1998-07       Impact factor: 2.610

Review 6.  Laminin isoforms in endothelial and perivascular basement membranes.

Authors:  Lema F Yousif; Jacopo Di Russo; Lydia Sorokin
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

Review 7.  Assembly, heterogeneity, and breaching of the basement membranes.

Authors:  Alexandros Glentis; Vasily Gurchenkov; Danijela Matic Vignjevic
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

Review 8.  Extracellular matrix and heart development.

Authors:  Marie Lockhart; Elaine Wirrig; Aimee Phelps; Andy Wessels
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-05-25

9.  Qualitative alterations in laminin expression in experimental lupus nephritis.

Authors:  C J Kootstra; E C Bergijk; A Veninga; F A Prins; E de Heer; D R Abrahamson; J A Bruijn
Journal:  Am J Pathol       Date:  1995-08       Impact factor: 4.307

Review 10.  Perlecan and tumor angiogenesis.

Authors:  Xinnong Jiang; John R Couchman
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.